Malaria: Clinical Trials

9 trials for Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Terminated 9

Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing a Risk Model for G6PD Deficiency
primaquine, chloroquine + primaquine - Malaria, Vivax, G6PD Deficiency
Phase 4TerminatedPATH542018-05-072021-11-12
Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Artemether/Lumefantrine (AL) - HIV Infection, Malaria
Phase 4TerminatedInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group192012-02-012014-05-19
Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)
Mefloquine- Artesunate, Artemether-Lumefantrine, Chloroquine - Plasmodium Vivax Malaria
Phase 4TerminatedCenters for Disease Control and Prevention162011-02-012012-04-13
Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Falciparum in Pregnancy in Brazil
Artemether-Lumefantrine, Mefloquine- Artesunate - Malaria
Phase 4TerminatedCenters for Disease Control and Prevention62010-11-012012-04-13
A Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon Islands
Sulphadoxine-pyrimethamine, Chloroquine prophylaxis - Malaria, Malaria in Pregnancy
Phase 4TerminatedMinistry of Health and Medical Services, Solomon Islands25042009-08-012010-07-07
Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children
Sulfadoxine Pyrimethamine - Malaria
Phase 4TerminatedAlbert Schweitzer Hospital, Netherlands1392007-03-012007-08-10
Randomized Trial on Effectiveness of ACTs in Ghana
Artesunate plus Amodiaquine, Artemether-Lumefantrine - Malaria, Falciparum
Phase 4TerminatedBernhard Nocht Institute for Tropical Medicine2452006-09-012007-11-27
Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function
Artemether-lumefantrine - Malaria, Falciparum
Phase 4TerminatedNovartis Pharmaceuticals2652005-06-012012-04-27
Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine
Bacille Calmette Guerin (BCG) - Malaria
Phase 4TerminatedBandim Health Project28712002-07-012008-10-21

Narrower conditions

Malaria, Falciparum (3)  ·  Malaria, Vivax (2)  ·  Anemia (1)  ·  Glucosephosphate Dehydrogenase Deficiency (1)  ·  HIV Infections (1)  ·  Infant Death (1)

Broader conditions

Infections (9)  ·  Mosquito-Borne Diseases (9)  ·  Parasitic Diseases (9)  ·  Protozoan Infections (9)  ·  Vector Borne Diseases (9)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Blood-Borne Infections (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Communicable Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Artemether, Lumefantrine Drug Combination (5)  ·  Chloroquine (2)  ·  fanasil, pyrimethamine drug combination (2)  ·  Amodiaquine (1)  ·  Artesunate (1)  ·  Primaquine (1)  ·  lactitol (1)

Sponsors

Centers for Disease Control and Prevention (2)  ·  Albert Schweitzer Hospital, Netherlands (1)  ·  Bandim Health Project (1)  ·  Bernhard Nocht Institute for Tropical Medicine (1)  ·  International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1)  ·  Ministry of Health and Medical Services, Solomon Islands (1)  ·  Novartis Pharmaceuticals (1)  ·  PATH (1)

Countries

Brazil (2)  ·  Gabon (1)  ·  Ghana (1)  ·  Guinea-Bissau (1)  ·  Malawi (1)  ·  Solomon Islands (1)  ·  Thailand (1)  ·  Uganda (1)

Top investigators

Anna Maria van Eijk, MD PhD (1)  ·  Daniel Ansong, MD (1)  ·  Francesca Aweeka, Pharm.D. (1)  ·  Martin P Grobusch, MD (1)  ·  Meghna Desai, MPH PhD (1)  ·  Meghna Desai, PhD MPH (1)  ·  Peter Aaby (1)  ·  Saadou Issifou, MD MSc (1)

Results publications

PMID 21569596, PMID 38828109

NIH funding

U01AI068632 (1)